These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27940765)

  • 21. Update on therapeutic developments for hereditary angioedema.
    Christiansen SC; Zuraw BL
    Allergy Asthma Proc; 2009; 30(5):500-5. PubMed ID: 19843404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current management options for hereditary angioedema.
    Bork K
    Curr Allergy Asthma Rep; 2012 Aug; 12(4):273-80. PubMed ID: 22729959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing the female patient with hereditary angioedema.
    Banerji A; Riedl M
    Womens Health (Lond); 2016 Jun; 12(3):351-61. PubMed ID: 26978558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Icatibant for the treatment of hereditary angioedema.
    Cole SW; Lundquist LM
    Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
    Reshef A; Grivcheva-Panovska V; Kessel A; Kivity S; Klimaszewska-Rembiasz M; Moldovan D; Farkas H; Gutova V; Fritz S; Relan A; Giannetti B; Magerl M
    Pediatr Allergy Immunol; 2019 Aug; 30(5):562-568. PubMed ID: 30993784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
    Kawalec P; Holko P; Paszulewicz A; Obtułowicz K
    Pneumonol Alergol Pol; 2013; 81(2):95-104. PubMed ID: 23420425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management and prevention of hereditary angioedema attacks.
    Lumry WR
    Am J Manag Care; 2013 Jun; 19(7 Suppl):s111-8. PubMed ID: 23844783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An ABC of the Warning Signs of Hereditary Angioedema.
    Grumach AS; Ferraroni N; Olivares MM; López-Serrano MC; Bygum A
    Int Arch Allergy Immunol; 2017; 174(1):1-6. PubMed ID: 28950264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countries.
    Wahn V; Aberer W; Aygören-Pürsün E; Bork K; Eberl W; Faßhauer M; Krüger R; Magerl M; Martinez-Saguer I; Späth P; Staubach-Renz P; Weber-Chrysochoou C
    Pediatr Allergy Immunol; 2020 Nov; 31(8):974-989. PubMed ID: 32524650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.
    Bernstein JA; Moellman JJ
    Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Pattern and Acute and Long-term Management of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency.
    Gómez-Traseira C; Pérez-Fernández E; López-Serrano MC; García-Ara MC; Pedrosa M; López-Trascasa M; Caballero T
    J Investig Allergol Clin Immunol; 2015; 25(5):358-64. PubMed ID: 26727765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facilitating home-based treatment of hereditary angioedema.
    Bernstein JA; Riedl M; Zacek L; Shapiro RS
    Allergy Asthma Proc; 2015; 36(2):92-9. PubMed ID: 25551795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency.
    Zuraw BL; Banerji A; Bernstein JA; Busse PJ; Christiansen SC; Davis-Lorton M; Frank MM; Li HH; Lumry WR; Riedl M;
    J Allergy Clin Immunol Pract; 2013; 1(5):458-67. PubMed ID: 24565617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of pregnancies in a hereditary angioedema patient after treatment with attenuated androgens since childhood.
    Farkas H; Veszeli N; Csuka D; Temesszentandrási G; Tóth F; Kőszegi L; Varga L
    J Obstet Gynaecol; 2015 Jan; 35(1):89-90. PubMed ID: 24921190
    [No Abstract]   [Full Text] [Related]  

  • 35. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
    Bork K
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema.
    Frank MM
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S23-9. PubMed ID: 18220149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New therapies for hereditary angioedema: disease outlook changes dramatically.
    Frank MM; Jiang H
    J Allergy Clin Immunol; 2008 Jan; 121(1):272-80. PubMed ID: 18206518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.
    Farkas H; Reshef A; Aberer W; Caballero T; McCarthy L; Hao J; Nothaft W; Schranz J; Bernstein JA; Li HH
    J Allergy Clin Immunol Pract; 2017; 5(6):1671-1678.e2. PubMed ID: 28601641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
    Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
    Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New treatment options for acute edema attacks caused by hereditary angioedema.
    Thomas MC; Shah S
    Am J Health Syst Pharm; 2011 Nov; 68(22):2129-38. PubMed ID: 22058099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.